Loading clinical trials...
Loading clinical trials...
The overall aim of this observational study is to generate real-world evidence on the pre- and post-diagnosis disease journeys, including baseline characteristics, treatment patterns and selected clin...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
AstraZeneca Clinical Study Information Center
CONTACT
1-877-240-9479information.center@astrazeneca.comLead Sponsor
AstraZeneca
NCT06318260 · ATTR Amyloidosis Wild Type
NCT06367842 · ATTR Amyloidosis, Cardiopathy, and more
NCT06261216 · Amyloid Cardiomyopathy, Wild Type ATTR Amyloidosis
NCT06186167 · Amyloid, Cardiac Amyloidosis, and more
NCT02797847 · Transthyretin-mediated Amyloidosis (ATTR Amyloidosis)
Research Site
Eden Prairie, Minnesota
Research Site
Calgary, Alberta
Research Site
Beijing
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions